Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model

NeuroImage

Volumn 66, Issue , 2013, Pages 133-141

  Kerbler, Georg M ^a   Hamlin, Adam S ^a   Pannek, Kerstin ^a   Kurniawan, Nyoman D ^a   Keller, Marianne D ^a   Rose, Stephen E ^a   Coulson, Elizabeth J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer's disease; Cholinergic basal forebrain; Diffusion tensor imaging; MRI; Neurodegeneration; Tractography

Indexed keywords

ANALGESIC AGENT; CHOLINE ACETYLTRANSFERASE; ENROFLOXACIN; NEUROTROPHIN RECEPTOR P75; TORBOGESIC; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN DEGENERATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATION; DIFFUSION WEIGHTED IMAGING; FRACTIONAL ANISOTROPY; HIPPOCAMPUS; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; STEREOTACTIC PROCEDURE; TRACTOGRAPHY; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DIFFUSION TENSOR IMAGING; DISEASE MODEL; FOREBRAIN; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; PATHOLOGY; PROCEDURES;

ALZHEIMER DISEASE; ANIMALS; BASAL FOREBRAIN; CHOLINERGIC NEURONS; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION;

EID: 84869784887     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.10.075     Document Type: Article

References (46)

1. Badea A., Johnson G.A., Jankowsky J.L. Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. Neuroimage 2010, 50:416-427.
2. Berger-Sweeney J., Stearns N.A., Murg S., Floerke-Nashner L.R., Lappi D.A., Baxter M.G. Selective immunolesions of cholinergic neurons in mice: effects on neuranatomy, neurochemistry, and behavior. J. Neurosci. 2001, 21:8164-8173.
3. Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol. 1996, 6:427-446.
4. Cole A.E., Nicoll R.A. Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells. J. Physiol. 1984, 352:173-188.
5. Filippi M., Agosta F. Structural and functional network connectivity breakdown in Alzheimer's disease studied with magnetic resonance imaging techniques. J. Alzheimers Dis. 2011, 24:455-474.
6. Franklin K.J.B., Paxinos G. The Mouse Brain in Stereotaxic Coordinates Third Edition 2007, Academic Press, San Diego.
7. Gartner U., Hartig W., Brauer K., Bruckner G., Arendt T. Immunofluorescence and immunoelectron microscopic evidence for differences in myelination of GABAergic and cholinergic septohippocampal fibres. Int. J. Dev. Neurosci. 2001, 19:347-352.
8. George S., Mufson E.J., Leurgans S., Shah R.C., Ferrari C., Detoledo-Morrell L. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol. Aging 2009, 32:1756-1764.
9. Grothe M., Zaborszky L., Atienza M., Gil-Neciga E., Rodriguez-Romero R., Teipel S.J., Amunts K., Suarez-Gonzalez A., Cantero J.L. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cereb. Cortex 2010, 20:1685-1695.
10. Grothe M., Heinsen H., Teipel S.J. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer's disease. Biol. Psychiatry 2011, 71:805-813.
11. Hall A.M., Moore R.Y., Lopez O.L., Kuller L., Becker J.T. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement. 2008, 4:271-279.
12. Harms M.P., Kotyk J.J., Merchant K.M. Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging. Exp. Neurol. 2006, 199:408-415.
13. Hort J., Laczo J., Vyhnalek M., Bojar M., Bures J., Vlcek K. Spatial navigation deficit in amnestic mild cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4042-4047.
14. Jones D.K. Challenges and limitations of quantifying brain connectivity in vivo with diffusion MRI. Imaging Med. 2010, 2:341-355.
15. Jones D.K., Horsfield M.A., Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn. Reson. Med. 1999, 42:515-525.
16. Kiuchi K., Morikawa M., Taoka T., Nagashima T., Yamauchi T., Makinodan M., Norimoto K., Hashimoto K., Kosaka J., Inoue Y., Inoue M., Kichikawa K., Kishimoto T. Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: a diffusion tensor tractography study. Brain Res. 2009, 1287:184-191.
17. Kokjohn T.A., Roher A.E. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement. 2009, 5:340-347.
18. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008, 42:19-27.
19. Maheswaran S., Barjat H., Rueckert D., Bate S.T., Howlett D.R., Tilling L., Smart S.C., Pohlmann A., Richardson J.C., Hartkens T., Hill D.L., Upton N., Hajnal J.V., James M.F. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI. Brain Res. 2009, 1270:19-32.
20. Mancuso C., Siciliano R., Barone E., Butterfield D.A., Preziosi P. Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. Expert Opin. Investig. Drugs 2011, 20:1243-1261.
21. Melhem E.R., Mori S., Mukundan G., Kraut M.A., Pomper M.G., van Zijl P.C. Diffusion tensor MR imaging of the brain and white matter tractography. Am. J. Roentgenol. 2002, 178:3-16.
22. Mesulam M.M., Mufson E., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connectinos of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 1983, 214:170-197.
23. Moldrich R.X., Pannek K., Hoch R., Rubenstein J.L., Kurniawan N.D., Richards L.J. Comparative mouse brain tractography of diffusion magnetic resonance imaging. Neuroimage 2010, 51:1027-1036.
24. Moreau P.H., Cosquer B., Jeltsch H., Cassel J.C., Mathis C. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 2008, 18:610-622.
25. Mueggler T., Meyer-Luehmann M., Rausch M., Staufenbiel M., Jucker M., Rudin M. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur. J. Neurosci. 2004, 20:811-817.
26. Mufson E. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat. 2003, 26:233-242.
27. Mufson E., Bothwell M., Hersh L.B., Kordower J.H. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J. Comp. Neurol. 1989, 196-217.
28. NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 2002, 443:136-153.
29. Muth K., Schonmeyer R., Matura S., Haenschel C., Schroder J., Pantel J. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region. Biol. Psychiatry 2010, 67:588-591.
30. Oishi K., Akhter K., Mielke M., Ceritoglu C., Zhang J., Jiang H., Li X., Younes L., Miller M.I., van Zijl P.C., Albert M., Lyketsos C.G., Mori S. Multi-modal MRI analysis with disease-specific filtering: intial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front. Neurol. 2011, 2:54.
31. Perry T.A., Hodges H., Gray J.A. Behavioural, histological and immunocytochemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system. Brain Res. Bull. 2001, 54:29-49.
32. Pierpaoli C., Jezzard P., Basser P.J., Barnett A., Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201:637-648.
33. Pievani M., Agosta F., Pagani E., Canu E., Sala S., Absinta M., Geroldi C., Ganzola R., Frisoni G.B., Filippi M. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum. Brain Mapp. 2010, 31:1862-1875.
34. Rossner S. Cholinergic immunolesions by 192-IgG-Saporin - a useful tool to stimulate pathogenic aspects of Alzheimer's disease. Int. J. Dev. Neurosci. 1997, 15:835-850.
35. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23:208-219.
36. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E.J. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31:1487-1505.
37. Sun S.W., Song S.K., Lin S.J., Holtzman D.M., Merchant K.M., Kotyk J.J. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp. Neurol. 2005, 191:77-85.
38. Teipel S.J., Meindl T., Grinberg L., Grothe M., Cantero J.L., Reiser M.F., Moller H.J., Heinsen H., Hampel H. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Hum. Brain Mapp. 2010, 32:1349-1362.
39. Thiessen J.D., Glazner K.A., Nafez S., Schellenberg A.E., Buist R., Martin M., Albensi B.C. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease. Brain Struct. Funct. 2010, 215:29-36.
40. Tournier J.D., Calamante F., Connelly A. MRtrix: diffusion tractography in crossing fiber regions. Int. J. Imaging Syst. Technol. 2012, 22:53-66.
41. Tuch D.S., Salat D.H., Wisco J.J., Zaleta A.K., Hevelone N.D., Rosas H.D. Choice reaction time performance correlates with diffusion anisotropy in white matter pathways supporting visuospatial attention. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12212-12217.
42. Unrath A., Klose U., Grodd W., Ludolph A.C., Kassubek J. Directional colour encoding of the human thalamus by diffusion tensor imaging. Neurosci. Lett. 2008, 434:322-329.
43. Wainer B.H., Levey A.I., Rye D.B., Mesulam M.M., Mufson E.J. Cholinergic and non-cholinergic septohippocampal pathways. Neurosci. Lett. 1985, 54:45-52.
44. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
45. Wu Q., Butzkueven H., Gresle M., Kirchhoff F., Friedhuber A., Yang Q., Wang H., Fang K., Lei H., Egan G.F., Kilpatrick T.J. MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerve. Neuroimage 2007, 37:1138-1147.
46. Ypsilanti A.R., Girao da Cruz M.T., Burgess A., Aubert I. The length of hippocampal cholinergic fibers is reduced in the aging brain. Neurobiol. Aging 2008, 29:1666-1679.